Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003793 · ClinicalTrials.gov registry record
Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 294
- Enrollment target
NCT00003793 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 294 participants.
The verdict
NCT00003793 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 294 participants
- Enrollment target
Study Summary
RATIONALE: Determination of genetic markers for soft tissue sarcoma or rhabdomyosarcoma may help doctors identify patients who are at risk for therapy-related leukemia. PURPOSE: Clinical trial to study genetic testing of children with soft tissue sarcoma or rhabdomyosarcoma to identify children who are at risk of developing leukemia from the chemotherapy used to treat sarcoma.
Interventions
- GENETIC mutation analysis
- GENETIC clonality analysis
- GENETIC microsatellite instability analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 1998-12 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003793
The ClinicalTrials.gov registry entry for NCT00003793 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 294 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which mutation analysis is the first listed.
NCT00003793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003793 about?
NCT00003793 is a clinical study titled "Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma". RATIONALE: Determination of genetic markers for soft tissue sarcoma or rhabdomyosarcoma may help doctors identify patients who are at risk for therapy-related leukemia. PURPOSE: Clinical trial to study genetic testing of children with soft tissue sarcoma or rhabdomyosarcoma to identify children who...
What is the current status of trial NCT00003793?
This trial is currently completed. The enrollment target is 294 participants. The study started on 1998-12. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00003793?
The interventions under investigation include: mutation analysis (GENETIC), clonality analysis (GENETIC), microsatellite instability analysis (GENETIC).
Who is sponsoring clinical trial NCT00003793?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.